Our objective is to achieve personalized pharmacotherapy to meet specific patient needs, enhancing therapeutic outcomes and minimizing adverse reactions.
Our lab enhances clinical decision-making through the use of modeling and simulation tools in drug development. By integrating data from preclinical studies into early clinical trials, we establish the optimal dosing for clinical application.